In some brain cancer cells, a mutated form of isocitrate...

In some brain cancer cells, a mutated form of isocitrate dehydrogenase, instead of catalyzing the oxidation of the secondary alcohol of isocitrate, catalyzes the reduction of $\alpha$ -ketoglutarate. Draw the product of the reaction.

Key Concepts

Enzyme Mutation in Cancer

Certain enzymes can undergo mutations in cancer cells which alter their normal catalytic activities. In the context of brain cancer, mutations in isocitrate dehydrogenase change its typical reaction pathway, leading to the production of an abnormal metabolite. This alteration can contribute to oncogenic processes by disrupting normal metabolic and regulatory functions within the cell.

Enzyme Catalysis

Enzymes accelerate chemical reactions by lowering the activation energies required to convert substrates into products. They achieve this through specific interactions with their substrates. Mutations can modify these interactions, potentially reversing the usual direction of a reaction or leading to the formation of atypical products.

Reduction Reactions in Metabolism

Reduction reactions involve the gain of electrons or hydrogen atoms by a molecule, which is a fundamental process in cellular metabolism. In this context, the mutated enzyme catalyzes the reduction of ?-ketoglutarate, leading to the production of a metabolite that is not typically produced by the normal enzyme activity.

Oncometabolite Formation

The mutated enzyme's activity results in the production of an oncometabolite, which is a metabolite that supports cancer development. In this case, the abnormal reduction of ?-ketoglutarate yields a hydroxy derivative that can interfere with normal cellular processes, influencing cell growth and survival in a way that promotes tumorigenesis.

Please give Ace some feedback